Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta‐analysis of randomized trials-Reference-Cited by-同舟云学术

Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta‐analysis of randomized trials

Published:2017-06 Issue:4 Volume:5 Page:511-518
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Facciorusso Antonio¹²,Bellanti Francesco¹,Villani Rosanna¹,Salvatore Veronica³,Muscatiello Nicola²,Piscaglia Fabio³,Vendemiale Gianluigi¹,Serviddio Gaetano¹

Affiliation:

1. Department of Medical and Surgical SciencesC.U.R.E. Centre for Liver Diseases Research and TreatmentInstitute of Internal MedicineUniversity of FoggiaFoggiaItaly

2. Department of Medical SciencesGastroenterology UnitUniversity of FoggiaFoggiaItaly

3. Department of Medical and Surgical SciencesInternal Medicine UnitUniversity of BolognaBolognaItaly

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640616673516

Reference22 articles.

1. Hepatocellular Carcinoma

2. EASL‐EORTC clinical practice guidelines: Management of hepatocellular carcinoma.J Hepatol2012; 56: 908–943.

3. Management of hepatocellular carcinoma: An update